Log In
BCIQ
Print this Print this
 

Cancer/testis antigen 1B (NY-ESO-1) (CTAG1B)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Cancer/testis antigen 1B (NY-ESO-1) (CTAG1B)

BCIQ
Print ChartPrint this
1 - Cancer 2 - Cancer 3 - Cancer 2 - Cancer
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase II
Cancer

2

3

2

1




 Products Targeting Cancer/testis antigen 1B (NY-ESO-1) (CTAG1B)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$601.7M

$45.3M

$556.4M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today